ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Targeted Mechanogenetics to Modulate Specific Deep Neural Circuits.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sonogenetics utilizes ultrasound for targeted, cell-type-specific modulation of neuronal activity. However, manipulating specific circuits within complex brain areas poses significant challenges due to heterogenous cell types with varying inherent sonosensitivity. Building on previous gas-vesicle-assisted ultrasound neuromodulation studies, we investigate an in vivo nanobubble-enhanced sonogenetic strategy, termed mechanogenetics, for circuit-level neural modulation. Application of this approach to distinct brain regions increased electromyography responses following motor-cortex stimulation and enhanced neural activity in deep-brain regions. Importantly, mechanogenetics enables us to modulate neural circuits controlling feeding behavior by specifically stimulating the mouse lateral hypothalamus (LH), with minimal disturbance in adjacent areas. The observed mechanogenetically-induced decreases in feeding behavior were further found to be mediated by LH-glutamatergic inputs to the ventral tegmental area. Furthermore, assessments of neural integrity, inflammation, and apoptosis support biosafety under the tested conditions. These findings demonstrate the feasibility of applying mechanogenetics to a behaviorally relevant deep neural circuit and provide a framework for localized, genetically targeted ultrasound neuromodulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.